Shares of GBS Inc. (NYSE:GBS – Get Free Report) were down 2.7% during trading on Wednesday . The company traded as low as $2.40 and last traded at $2.48. 279,862 shares changed hands during trading, a decline of 71% from the average daily volume of 955,325 shares. The stock had previously closed at $2.55.
GBS Stock Performance
The firm has a market capitalization of $36.93 million, a PE ratio of -4.43 and a beta of 1.32. The company’s 50 day simple moving average is $1.59 and its 200-day simple moving average is $1.53.
About GBS
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
See Also
- Five stocks we like better than GBS
- Financial Services Stocks Investing
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Why Are These Companies Considered Blue Chips?
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What is a Dividend King?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
